Article
Control of Il-6 Expression and Response in Fibroblasts from Patients with Systemic Sclerosis
1 Jan 1994
Abstract excerpt
Systemic sclerosis (SSc) is an autoimmune connective tissue disease of unknown etiology in which aberrant fibroblast function results in fibrosis of the skin and internal organs. A distinguishing feature of dermal fibroblasts cultured from SSc lesions is that they produce constitutively, i.e., without exogenous stimulation, as much as 30-fold more interleukin-6 (IL-6) than do normal fibroblasts. The present study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
